Understanding ligand binding within the insulin-like growth factor family with direct application to cancer therapeutic design [ 2017 - ]

Research Grant

Researchers: A/Pr Michael Lawrence (Principal investigator) ,  A/Pr Christopher Burns

Brief description Cancer is a devastating disease and there is an imperative to develop new therapeutics. The so-called insulin-like growth factors are molecules that play a key role in the initiation and progression of cancer. Here we seek to understand how these molecules interact with cells and to develop drugs that might block their action.

Funding Amount $861,235.00

Funding Scheme Project Grants

Notes Standard Project Grant